MALVERN, PA — Endo, Inc. (OTCQX: NDOI) has taken a significant step towards listing its shares on the New York Stock Exchange (NYSE) by filing a registration statement with the U.S. Securities and Exchange Commission (SEC) on July 12, 2024. This move is part of the company’s broader strategy to enhance long-term value for stakeholders.
The registration statement, filed on Form S-1, aims to register certain shares of common stock held by current shareholders. Importantly, Endo is not issuing or selling new shares as part of this process. Consequently, the total number of outstanding shares will remain unchanged.
Currently, Endo’s shares are traded on the OTCQX® Best Market, a platform known for its high standards in financial disclosure and trading statistics. The company expects its common stock to start trading on the NYSE later in 2024, pending SEC approval and other customary conditions.
Endo focuses on delivering a diversified portfolio of on-market medicines and a pipeline of innovative product candidates. The NYSE listing is seen as a crucial step in enhancing the company’s market visibility and investor base.
“This filing marks an important milestone in our efforts to create long-term value for our stakeholders,” said a representative from Endo. “We believe that listing on the NYSE will provide greater liquidity and access to capital, supporting our growth initiatives.”
Investors who currently hold Endo’s common stock or are considering buying shares can continue to find financial disclosures and trading statistics on otcmarkets.com. The company emphasized that this announcement does not constitute an offer to sell or a solicitation to buy any securities. Any transactions will comply with the registration requirements of the Securities Act of 1933, as amended.
Endo’s move to the NYSE is expected to increase its market presence and attract a broader range of investors, positioning the company for future growth and development.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.